Geneplus IPO

Geneplus locks onto targeted medicine for IPO pitch

After a post-Covid earnings dip, the company is seeking a stable future as a provider of data and diagnostics for precision medicine and disease prevention   Key Takeaways: The company’s…
Jinxin does health AI

BRIEF: Airdoc Tech approved for H-share full circulation

Beijing Airdoc Technology Co. Ltd. (2251.HK) announced on Monday that the China Securities Regulatory Commission (CSRC) has approved its plan to convert 50.15 million of its domestic shares into H-shares…

AI Pharma Startup METiS Raises $150 Million. IPO in Sight?

Company has conducted five financing rounds since its establishment in January 2020 Key takeaways: METiS Pharmaceuticals has completed five funding rounds since its establishment in January 2020, including the latest…